OBS Pakistan   Report issue

For profit Phase 4
Founded: Karachi Pakistan (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2018
NCT03486561
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

OBS Pakistan

Active Ingredients

Drugs in Phase 4 Trials (2)

norfloxacin (noroxin) (1 trial)

ranolazine (ranexa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina, Stable (Phase 4)

Coronary Artery Disease (Phase 4)

Heart Diseases (Phase 4)

Myocardial Ischemia (Phase 4)

Urinary Tract Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2